Use of the dTAG system <i>in vivo</i> to degrade CDK2 and CDK5 in adult mice and explore potential safety liabilities
Paul Yenerall(Pfizer (United States)), Wenyue Hu(Pfizer (United States))
Cited by 15
Related Papers
No related papers found
Powered by citation graph analysis